吉林中医药2025，Vol.45Issue(6)：676-679,4.DOI:10.13463/j.cnki.jlzyy.2025.06.014
仝小林治疗变应性支气管肺曲霉病验案1例
A case study on the treatment of allergic bronchopulmonary aspergillosis by Professor Tong Xiaolin
摘要
Abstract
Allergic bronchopulmonary aspergillosis is a recurrent lung disease caused by Aspergillus fumigatus.In its acute episodes,western medicine treats the disease with corticosteroids,antifungal and anti-inflammatory drugs,achieving an instant curative effect.While in the stable phase of the disease,traditional Chinese medicine(TCM)has unique advantages in regulating its overall condition and reducing the side effects of corticosteroids.This article discusses the treatment of allergic bronchopulmonary aspergillosis from the perspective of wind-damp in zang-fu viscera.For patients with phlegm and blood stasis obstructing the lungs as the main pathogenesis,based on resolving phlegm,removing blood stasis,and purging the lungs,Chinese drugs are used in replacement of corticosteroids for its treatment,which can not only regulate its states but also target its symptoms,providing a new idea for the clinical diagnosis and treatment of allergic bronchopulmonary aspergillosis.关键词
变应性支气管肺曲霉病/宣白承气汤/激素/疑难病/仝小林Key words
allergic bronchopulmonary aspergillosis/Xuanbai Chengqi Decoction/corticosteroids/complicated diseases/Tong Xiaolin分类
中医学引用本文复制引用
樊瑷晗,董立硕,李佳芮,孙阿茹,亢泽峥,高佳琪,胡月,张莉莉..仝小林治疗变应性支气管肺曲霉病验案1例[J].吉林中医药,2025,45(6):676-679,4.基金项目
北京市自然科学基金青年项目(7244497) （7244497）
中国中医科学院广安门医院临床医学研究中心建设专项(2022LYJSZX28,2022LYJSZX08) （2022LYJSZX28,2022LYJSZX08）
中央级公益性科研院所基本科研业务费专项资金资助项目(ZZ16-XRZ-042) （ZZ16-XRZ-042）
中华中医药学会(2023-2025年度)青年人才托举工程项目(CACM-2023-QNRC2-A08) （2023-2025年度）
中国中医科学院广安门医院护航工程(骨干人才培养项目)(GAMHH9324025) （骨干人才培养项目）
吉林省在站博士后创新项目(14090703) （14090703）
中国中医科学院科技创新工程重大攻关项目(C12021A01602) （C12021A01602）
